Texas Attorney General Sues Tylenol Makers Concerning Autism Assertions

Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, claiming the firms withheld potential risks that the medication created to pediatric brain development.

The court filing arrives four weeks after President Donald Trump publicized an unsubstantiated connection between taking acetaminophen - alternatively called paracetamol - throughout gestation and autism in offspring.

The attorney general is filing suit against Johnson & Johnson, which once produced the drug, the only pain reliever suggested for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he said they "betrayed America by profiting off of pain and marketing drugs without regard for the risks."

Kenvue says there is insufficient reliable data linking acetaminophen to autism.

"These companies lied for decades, knowingly endangering countless individuals to line their pockets," the attorney general, a Republican, said.

Kenvue stated officially that it was "seriously troubled by the spread of false claims on the security of paracetamol and the likely effects that could have on the well-being of American women and children."

On its website, Kenvue also stated it had "regularly reviewed the relevant science and there is no credible data that shows a established connection between using acetaminophen and autism."

Groups acting on behalf of doctors and medical practitioners share this view.

ACOG has said paracetamol - the primary component in Tylenol - is a restricted selection for pregnant women to treat discomfort and elevated temperature, which can present serious health risks if not addressed.

"In over twenty years of research on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the usage of paracetamol in any period of pregnancy results in neurodevelopmental disorders in children," the organization commented.

The court filing references recent announcements from the previous government in claiming the drug is reportedly hazardous.

Last month, Trump raised alarms from public health officials when he instructed pregnant women to "struggle intensely" not to take acetaminophen when ill.

Federal regulators then published an announcement that physicians should consider limiting the use of acetaminophen, while also stating that "a proven link" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had pledged in spring to initiate "a massive testing and research effort" that would establish the cause of autism in a short period.

But authorities warned that finding a sole reason of autism - thought by researchers to be the result of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and disability that affects how individuals encounter and interact with the environment, and is diagnosed using physician assessments.

In his court filing, the attorney general - aligned with the former president who is seeking US Senate - claims the manufacturer and J&J "willfully ignored and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the firms "remove any promotional materials" that asserts acetaminophen is secure for women during pregnancy.

The court case echoes the grievances of a collection of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in recently.

Judicial authorities dismissed the lawsuit, declaring studies from the plaintiffs' authorities was not conclusive.